State of Wisconsin Investment Board’s ANI Pharmaceuticals ANIP Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $603K | Sell |
7,835
-8,094
| -51% | -$632K | ﹤0.01% | 1901 |
|
|
2025
Q4 | $1.26M | Sell |
15,929
-4,143
| -21% | -$359K | ﹤0.01% | 1575 |
|
|
2025
Q3 | $1.84M | Buy |
20,072
+11,706
| +140% | +$955K | ﹤0.01% | 1398 |
|
|
2025
Q2 | $546K | Sell |
8,366
-105
| -1% | -$6.84K | ﹤0.01% | 1816 |
|
|
2025
Q1 | $567K | Buy |
8,471
+121
| +1% | +$7.23K | ﹤0.01% | 1706 |
|
|
2024
Q4 | $462K | Sell |
8,350
-81
| -1% | -$4.65K | ﹤0.01% | 1847 |
|
|
2024
Q3 | $503K | Hold |
8,431
| – | – | ﹤0.01% | 1871 |
|
|
2024
Q2 | $537K | Sell |
8,431
-522
| -6% | -$33.9K | ﹤0.01% | 1791 |
|
|
2024
Q1 | $619K | Sell |
8,953
-1,026
| -10% | -$61.9K | ﹤0.01% | 1634 |
|
|
2023
Q4 | $550K | Sell |
9,979
-5,271
| -35% | -$290K | ﹤0.01% | 1680 |
|
|
2023
Q3 | $885K | Buy |
15,250
+4,808
| +46% | +$277K | ﹤0.01% | 1443 |
|
|
2023
Q2 | $562K | Sell |
10,442
-479
| -4% | -$21.2K | ﹤0.01% | 1771 |
|
|
2023
Q1 | $434K | Sell |
10,921
-1,209
| -10% | -$51K | ﹤0.01% | 1933 |
|
|
2022
Q4 | $488K | Sell |
12,130
-779
| -6% | -$29.3K | ﹤0.01% | 1905 |
|
|
2022
Q3 | $415K | Buy |
+12,909
| New | +$442K | ﹤0.01% | 2065 |
|
|
2022
Q2 | – | Sell |
-14,700
| Closed | -$413K | – | 2796 |
|
|
2022
Q1 | $413K | Buy |
+14,700
| New | +$548K | ﹤0.01% | 2002 |
|
|
2021
Q2 | – | Sell |
-12,500
| Closed | -$452K | – | 2067 |
|
|
2021
Q1 | $452K | Hold |
12,500
| – | – | ﹤0.01% | 1626 |
|
|
2020
Q4 | $363K | Sell |
12,500
-1,600
| -11% | -$45.8K | ﹤0.01% | 1635 |
|
|
2020
Q3 | $398K | Sell |
14,100
-600
| -4% | -$17.9K | ﹤0.01% | 1556 |
|
|
2020
Q2 | $475K | Buy |
14,700
+600
| +4% | +$21.5K | ﹤0.01% | 1447 |
|
|
2020
Q1 | $574K | Buy |
14,100
+400
| +3% | +$21.3K | ﹤0.01% | 1318 |
|
|
2019
Q4 | $845K | Hold |
13,700
| – | – | ﹤0.01% | 1283 |
|
|
2019
Q3 | $998K | Buy |
13,700
+2,100
| +18% | +$157K | ﹤0.01% | 1145 |
|
|
2019
Q2 | $954K | Buy |
11,600
+900
| +8% | +$64K | ﹤0.01% | 1154 |
|
|
2019
Q1 | $755K | Buy |
10,700
+2,400
| +29% | +$141K | ﹤0.01% | 1232 |
|
|
2018
Q4 | $374K | Buy |
8,300
+2,300
| +38% | +$121K | ﹤0.01% | 1382 |
|
|
2018
Q3 | $339K | Hold |
6,000
| – | – | ﹤0.01% | 1453 |
|
|
2018
Q2 | $401K | Hold |
6,000
| – | – | ﹤0.01% | 1384 |
|
|
2018
Q1 | $349K | Hold |
6,000
| – | – | ﹤0.01% | 1349 |
|
|
2017
Q4 | $387K | Hold |
6,000
| – | – | ﹤0.01% | 1325 |
|
|
2017
Q3 | $315K | Hold |
6,000
| – | – | ﹤0.01% | 1365 |
|
|
2017
Q2 | $281K | Buy |
+6,000
| New | +$289K | ﹤0.01% | 1373 |
|
Other funds holding ANIP
VCM
SCM
TCM
GAM
DTC
State of Wisconsin Investment Board's ANIP Position: Q1 2026 in Review
State of Wisconsin Investment Board reduced its ANI Pharmaceuticals (ANIP) stake by 51% in Q1 2026, selling an estimated $632K and leaving 7,835 shares worth $603K. The position accounts for ﹤0.01% of the portfolio, ranked #1901.
State of Wisconsin Investment Board first reported a position in ANIP in Q2 2017 and has held it in 32 quarters since. The position peaked at $1.84M in Q3 2025. 280 funds tracked by Wall St. Rank hold ANIP as of Q1 2026.
- State of Wisconsin Investment Board held 7,835 shares of ANI Pharmaceuticals worth $603K as of Q1 2026.
- State of Wisconsin Investment Board sold 8,094 ANI Pharmaceuticals shares in Q1 2026, an estimated $632K.
- ANI Pharmaceuticals made up ﹤0.01% of State of Wisconsin Investment Board's portfolio in Q1 2026, its #1901 holding.
- State of Wisconsin Investment Board first reported a position in ANI Pharmaceuticals in Q2 2017 and has held it in 32 quarters since.
- State of Wisconsin Investment Board's ANI Pharmaceuticals position peaked at $1.84M in Q3 2025.
- 280 funds tracked by Wall St. Rank held ANI Pharmaceuticals as of Q1 2026.
Based on State of Wisconsin Investment Board's 13F filing for Q1 2026, filed 15 May 2026.